Sanofi India Limited
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, epilepsy, anti-infectives, and central nervous system, as well as allergy, pain care, digestive, and nutritional health under the Lantus, Toujeo, S… Read more
Sanofi India Limited (SANOFI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.186x
Based on the latest financial reports, Sanofi India Limited (SANOFI) has a cash flow conversion efficiency ratio of 0.186x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹1.46 Billion) by net assets (₹7.82 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sanofi India Limited - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Sanofi India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sanofi India Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sanofi India Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sinostar Cable Co. Ltd.
SHE:300933
|
0.000x |
|
Tong Ren Tang Technologies Co. Ltd
PINK:TGRNF
|
-0.043x |
|
Nantong Haixing Electronics Co Ltd
SHG:603115
|
0.000x |
|
Fujian Yongfu Power Engineering Co Ltd Class A
SHE:300712
|
0.098x |
|
Shenzhen Etmade Automatic Equipment
SHE:300812
|
0.067x |
|
enCore Energy Corp.
V:EU
|
-0.073x |
|
Hyster-Yale Materials Handling Inc
NYSE:HY
|
0.067x |
|
Zhejiang Yankon Group Co Ltd
SHG:600261
|
0.022x |
Annual Cash Flow Conversion Efficiency for Sanofi India Limited (2004–2025)
The table below shows the annual cash flow conversion efficiency of Sanofi India Limited from 2004 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₹7.49 Billion | ₹4.51 Billion | 0.602x | +12.23% |
| 2024-12-31 | ₹8.61 Billion | ₹4.62 Billion | 0.536x | +136.29% |
| 2023-12-31 | ₹10.15 Billion | ₹2.30 Billion | 0.227x | -27.38% |
| 2022-12-31 | ₹12.76 Billion | ₹3.99 Billion | 0.313x | +24.47% |
| 2021-12-31 | ₹22.26 Billion | ₹5.59 Billion | 0.251x | -12.94% |
| 2020-12-31 | ₹21.19 Billion | ₹6.11 Billion | 0.288x | +70.83% |
| 2019-12-31 | ₹24.42 Billion | ₹4.12 Billion | 0.169x | +0.20% |
| 2018-12-31 | ₹22.19 Billion | ₹3.74 Billion | 0.168x | -21.53% |
| 2017-12-31 | ₹20.26 Billion | ₹4.35 Billion | 0.215x | +15.52% |
| 2016-12-31 | ₹17.36 Billion | ₹3.23 Billion | 0.186x | +41.87% |
| 2015-12-31 | ₹16.27 Billion | ₹2.13 Billion | 0.131x | -26.53% |
| 2014-12-31 | ₹14.86 Billion | ₹2.65 Billion | 0.178x | -11.89% |
| 2013-12-31 | ₹13.47 Billion | ₹2.73 Billion | 0.202x | -14.90% |
| 2012-12-31 | ₹12.04 Billion | ₹2.86 Billion | 0.238x | +29.53% |
| 2011-12-31 | ₹11.17 Billion | ₹2.05 Billion | 0.184x | +42.45% |
| 2010-12-31 | ₹10.14 Billion | ₹1.31 Billion | 0.129x | -12.71% |
| 2009-12-31 | ₹9.32 Billion | ₹1.38 Billion | 0.148x | +2.28% |
| 2008-12-31 | ₹8.29 Billion | ₹1.20 Billion | 0.144x | -1.97% |
| 2007-12-31 | ₹7.07 Billion | ₹1.04 Billion | 0.147x | -27.73% |
| 2006-12-31 | ₹6.08 Billion | ₹1.24 Billion | 0.204x | -32.31% |
| 2005-12-31 | ₹5.24 Billion | ₹1.58 Billion | 0.301x | +77.53% |
| 2004-12-31 | ₹4.22 Billion | ₹715.33 Million | 0.170x | -- |